Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference74 articles.
1. MRD testing in multiple myeloma: the main future driver for modern tailored treatment;Landgren;Semin Hematol,2018
2. Association of minimal residual disease with superior survival outcomes in patients with multiple myeloma: a meta-analysis;Munshi;JAMA Oncol,2017
3. International myeloma working group consensus criteria for response and minimal residual disease assessment in multiple myeloma;Kumar;Lancet Oncol,2016
4. Immunophenotype of normal vs. myeloma plasma cells: toward antibody panel specifications for MRD detection in multiple myeloma;Flores-Montero;Cytometry B Clin Cytom,2016
5. Quality assessment program for euroflow protocols: summary results of four-year (2010-2013) quality assurance rounds;Kalina;Cytom Part A,2015
Cited by 95 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Innate Immune Response and Epigenetic Regulation: A Closely Intertwined Tale in Inflammation;Advanced Biology;2024-09-12
2. Borassus flabellifer: A Multipurpose Tree with Potential Applications;Current Pharmacology Reports;2024-09-02
3. A roadmap towards improving outcomes in multiple myeloma;Blood Cancer Journal;2024-08-12
4. Liquid Biopsy in the Clinical Management of Cancers;International Journal of Molecular Sciences;2024-08-06
5. Pro- and anti-inflammatory cytokines are the game-changers in childhood obesity-associated metabolic disorders (diabetes and non-alcoholic fatty liver diseases);Reviews in Endocrine and Metabolic Disorders;2024-05-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3